Dermatology

Spesolimab, a monoclonal antibody targeting the interleukin (IL)-36 receptor, has been approved as the first GPP-specific therapy.

The findings of this study suggest that both 70% and 100% TCA achieve similar overall results.

Results suggest that standard HPV vaccination may offer a novel approach to actinic keratosis management.

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira.

A national cohort study found that veterans in the most disadvantaged areas had a higher risk of being diagnosed with thicker melanomas.

The study also highlighted the psychological burden of hyperhidrosis, linking the condition to increased anxiety, depression, and impaired quality of life.

A new study investigates the combination of nivolumab and hypofractionated radiotherapy in advanced melanoma.

Recent research highlights the role of gut microbiota in atopic dermatitis pathogenesis.